Ironwood Pharmaceuticals

-$0.14 (-1.26%) As of 5:08 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IRWD and other ETFs, options, and stocks.

About IRWD

Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need, leveraging demonstrated expertise and capabilities in GI diseases. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation.

CEO
Thomas A. McCourt
Employees
219
Headquarters
Boston, Massachusetts
Founded
1998

IRWD Key Statistics

Market cap
1.68B
Price-Earnings ratio
3.47
Dividend yield
—
Average volume
2.33M
High today
$11.15
Low today
$10.89
Open price
$11.05
Volume
926.46K
52 Week high
$14.27
52 Week low
$10.13

IRWD Earnings

$0.00
$0.12
$0.24
$0.36
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure